KNBWY – kirin hldgs co ltd s/adr (US:NASDAQ)
Stock Stats
News
3/3
04:20 pm
knbwy
Low
Kirin launches RTD brand Hyoketsu in US [Yahoo! Finance]
3/3
08:53 am
knbwy
Low
Kyowa Kirin stops development of skin condition treatment [Yahoo! Finance]
3/3
08:21 am
knbwy
Low
Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials [Yahoo! Finance]
3/2
06:09 am
knbwy
Low
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands [Yahoo! Finance]
2/27
08:52 pm
knbwy
Low
KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production [Yahoo! Finance]
Show more
Top News Gainers
7/18 Health experts denounce Scheer’s comments on Canada’s Food Guide as ‘irresponsible’ and ‘disingenuous’ [Toronto Globe and Mail (Ontario, Canada)] 3.0%
8/6 Kirin to take 30.3% stake in Fancl for $1.2 billion [Reuters] 2.2%
8/7 Australian regulator flags concerns over Saputo's Tasmanian cheese business buyout [Reuters] 1.9%
10/12 Lipo Naturals New Supplement with Setria® Offers "Most Potent" Form of Oral Glutathione (GSH) 0.7%
4/26 Japan's Kirin cuts full-year profit outlook on Lion unit impairment [Reuters] 0.7%
3/18 Kyowa Kirin Asia Pacific Announces Establishment of Subsidiary in Australia 0.3%
10/15 Kyowa Hakko's Setria® is the No. 1 Selling Brand of Glutathione 0.2%
3/31 Plant-Based Butter Startup Fora Sees Partnership Opportunities In Dairy Sector [Forbes] 0.1%
10/10 Kirin Holdings Co Ltd (OTCMKTS: KNBWY) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 0.0%
Top News Decliners
8/28 Kyowa Kirin Announces FDA Approval of NOURIANZ™ (istradefylline) for Use in Parkinson’s Disease -2.5%
4/4 Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US -2.2%
2/28 Dairy Farmers pull ad after complaints over alleged misleading the public [Business News Network (BNN) Energy & Resources (Canada)] -1.8%
3/6 Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients -0.8%
2/14 Ultragenyx and Kyowa's Crysvita shows long-term benefit in XLH study [Seeking Alpha] -0.5%
1/23 New Canada food guide has P.E.I. dairy farmers 'very concerned' [CBC (Canadian Broadcasting Corporation)] -0.2%
11/23 GSK and Kyowa Hakko Kirin inks deal in Japan for Daprodustat [Seeking Alpha] -0.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3